GlassScriptPhysician profile
Mason Adams
NPI 1770979882
$7,426.48
in general payments reported to CMS, 2019-2025
38 companies · $2,261 in 2025
The $2,261 reported for 2025 was more than what 82% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $638 · 2020: $788 · 2021: $220 · 2022: $771 · 2023: $1,646 · 2024: $1,104 · 2025: $2,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,578 · Travel and Lodging: $1,367 · Education: $64.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,578.35 |
| Travel and Lodging | $1,367.26 |
| Education | $64.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,520.54 | 2020-2025 | Skyrizi, Rinvoq, Linzess |
| Olympus Corporation of The Americas | $888.17 | 2019-2020 | |
| Boston Scientific Corporation | $707.71 | 2023-2025 | Orise, General - Therapies, Overstitch Nxt Endoscopic Suturing System |
| Takeda Pharmaceuticals U.S.A., INC. | $556.48 | 2021-2025 | Entyvio, Gattex, Livtencity |
| Ovesco Endoscopy USA, INC. | $451.36 | 2025 | |
| Intuitive Surgical, INC. | $424.12 | 2023 | Da Vinci Surgical System |
| Conmed Corporation | $380.31 | 2023-2025 | Conmed Biliary, Conmed Generators, Conmed Hemostasis |
| Janssen Biotech, INC. | $333.71 | 2020-2025 | Stelara, Tremfya |
| Cook Medical LLC | $271.04 | 2021-2025 | Hemospray |
| 3-D Matrix, INC. | $204.68 | 2023-2024 | |
| Olympus America INC. | $163.72 | 2023-2024 | Visiglide, Single Use Splinting Tube, Hanarostent Lowaxtm Duodenum/Pylorus(Nnn) |
| Intercept Pharmaceuticals, INC. | $153.67 | 2019-2023 | Ocaliva |
| Endogastric Solutions, INC | $147.61 | 2023 | Esophyx |
| Braintree Laboratories, INC. | $147.40 | 2022 | |
| Stryker Corporation | $143.83 | 2023-2025 | Augment Injectable, Prostep Mica |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mason Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.